Scientific Secretariat Antonio E. Alegria, Ph.D Balaraman Kalyanaraman, Ph.D. |
Organizational Secretariat Mr. Carlos Castañeda |
EPR 2010 Updates |
Invitation
On behalf of the Organizing Committee, it is our pleasure to extend a warm invitation to join us for EPR 2010, A Joint Conference of the 14th In Vivo ESR/EPR Spectroscopy & Imaging and the 11th International EPR Spin Trapping/Spin Labeling (EPR 2010) to be held at the Condado Plaza Hotel, San Juan, Puerto Rico on May 2 – 6, 2010.
EPR 2010, by its very nature, blends together a mixture of topics, combining some of the most prominent contributors from the joint fields with complementary but overlapping strengths. We have put together an outstanding program designed to encourage interaction and discussion. The agenda includes
- EPR Instrumentation: the Latest and the Greatest
- Protein Dynamics by Pulsed EPR
- In Vivo EPR Spectroscopy and Imaging
- EPR and Spin Trapping in Redox Biology
- Free Radicals in Rare Diseases
- Spin Trap/Spin Label Synthesis
- Spin Labeling in Membranes
- In Vivo Oximetry and Redox Imaging
- Novel Actions and Reactions of Quinones
- EPR Techniques in Metalloproteins
- EPR Dosimetry
- EPR Simulations
- Spin Traps and Nitroxides in Translational Research
- Oral presentations from selected abstracts
- Poster presentations
The field of EPR is expanding and exploring new frontiers. We would like to offer you an event of high scientific value and an outstanding venue. We hope that you enjoy the EPR 2010 conference and that your participation contributes to your professional development and relationships.
Antonio E. Alegria, Ph.D.
![]()
and
![]()
Balaraman Kalyanaraman, Ph.D.
Co-Chairs, EPR 2010
Funding for this conference was made possible (in part) by grant number 1R13CA150298-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.